Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text

 

Pipeline - FASN

 

About Fatty Acid Synthase (FASN)

FASN over-expression is one of the most common changes in cancer cells.

We have developed a novel chemical series which is effective in breast cancer cell models.

We are seeking a collaboration partner to fund the further development of these compounds.



Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701